Friday, 23 October 2026European Markets
ExploreSearch
ViaNews EU

Central Bank Policy

2 articles

ECB Faces March 19 Policy Test as 92,000 Jobs Lost, Oil Surges 36%

ECB Faces March 19 Policy Test as 92,000 Jobs Lost, Oil Surges 36%

The European Central Bank meets March 19 amid conflicting signals: February job losses hit 92,000 while oil prices jumped 36% on Iran conflict. Former Fed official Loretta Mester says central banks need 'convincing evidence' of inflation retreat before cutting rates, even as labor markets weaken.

ViaNews Editorial Team (Europe)•
Fed Signals More Rate Cuts as ECB Holds Firm, Widening Atlantic Monetary Divide

Fed Signals More Rate Cuts as ECB Holds Firm, Widening Atlantic Monetary Divide

Chicago Fed President Alan Goolsbee said interest rates can drop further in 2026 if inflation moderates, contrasting with the ECB's cautious stance. The divergence pressures the euro as US markets rally on dovish Fed signals while European policymakers maintain tighter conditions. Contactless payments in Finland jumped 23% to €8.4 billion in Q2 2025 as payment infrastructure evolves.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise Software Races to Govern and Consolidate Around Agentic AI
Enterprise software vendors are repositioning around autonomous AI agents. Salesforce is acquiring Braze, ServiceNow is launching agent governance tools (AI Passport, Super Intelligence Control Tower), SAP is pushing its 'Autonomous Enterprise', and Zeta is launching AthenaOS and its own inference model. Palantir is embedding itself in banking, aviation and sovereign AI infrastructure through partnerships with Customers Bank, Surf Air, Ondas and Armada. Governance, data sovereignty and enforced policy are emerging as preconditions for regulated sectors like finance. Investors such as Norwest see room to disrupt ERP and finance software, and they caution that AI should not be trusted with financial calculations. Consolidation and shareholder disputes (Salesforce/Braze, Tiny/Oso Cloud, ZenaTech/Boardwalktech) show the market reshaping.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,475 source documents archived
Query this data → isubstrate.com